More accurate detection of a specific molecular marker in leukemic cells will help assess measurable residual disease and guide treatment decisions, improving patient outcomes, report investigators in The Journal of Molecular Diagnostics Grant A. Challen, PhD, Division of Oncology, Department of Medicine, Washington University School of Medicine in St. Louis, lead investigator, has been published […]
New Assay Could Revolutionize Detection and Treatment of Acute Myeloid Leukemia
















































